Skip to main content
. 2015 Apr 9;6:282. doi: 10.3389/fmicb.2015.00282

Table 2.

Antibacterial activities of the reviewed drugs.

Drug Therapeutic use Antibacterial activity in vitro Antibacterial activity in vivo Reference
Gallium compounds Gallium nitrate: treatment of hypercalcemia of malignancy Growth inhibition of several recalcitrant bacterial pathogens (including clinical isolates) such as: Gram (-) Pseudomonas aeruginosa y A. baumanii and Gram (+) like Mycobacterium tuberculosis Effective against syphilis (Treponema cuniculi) in rabbits and trypanosomiasis in mice, guinea pigs, and monkeys Acute and chronic mice infections of P. aeruginosa A. baumannii infections in caterpillar and mice Levaditi et al. (1931), Olakanmi et al. (2000), Kaneko et al. (2007), DeLeon et al. (2009), Antunes et al. (2012), de Leseleuc et al. (2012)
5-Florouracil Anticancer drug Treatment of actinic keratosis and Bowen's disease Growth inhibition of Gram (+) and (-) bacterial species Inhibition of biofilm formation Repression of QS in P. aeruginosa Successful in clinical trials in humans, as external coating of central venous catheters Hussain et al. (1992), Ueda et al. (2009), Walz et al. (2010)
Ciclopirox Antifungal Bacteriostatic and bactericide activity, depending on concentration used, in laboratory and clinical isolates Not yet tested Carlson-Banning et al. (2013)
5-fluorocytosine Antifungal Inhibition of virulence factor production by P. aeruginosa Suppresses P. aeruginosa pathogenicity in a mouse model of lung infection Imperi et al. (2013a)
Azithromycin Antibiotic Inhibition of QS systems of P. aeruginosa Clinical evidence and clinical trials demonstrate efficacy in the treatment of chronic pulmonary infections of P. aeruginosa Imperi et al. (2014)
Niclosamide Antihelmintic Inhibition of QS systems of P. aeruginosa Reduction of P. aeruginosa pathogenicity in an insect model Imperi et al. (2013b)
Diflunisal Non-steroidal anti-inflammatory Potent virulence inhibitor for the USA300 strain of methicillin-resistant Staphylococcus aureus (MRSA) Not yet tested Khodaverdian et al. (2013)
Statins Lower plasma cholesterol levels Reduction of virulence factor production of P. aeruginosa Broad spectrum antibacterial effects Inhibition of S. pneumoniae attachment to lung and vascular tissue Rosch et al. (2010)
Pentetic acid Preparation of radiopharmaceuticals treatment of iron-storage disease and poisoning from heavy metals Reduction of virulence factor production of P. aeruginosa Effective to alleviate mice airway infections Gi et al. (2014)
Terfenadine Antihistamine Inhibit growth of several pathogenic bacteria, including S. aureus and M. tuberculosis Not yet tested Perlmutter et al. (2014)
Zafirlukast Treatment of asthma Antimycobacterial Not yet tested Pinault et al. (2013)